Suppression of murine cerebral F2-isoprostanes and F 4-neuroprostanes from excitotoxicity and innate immune response in vivo by α- Or γ-tocopherol

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 827, Issue 1, 2005, Pages 88-93

  Milatovic, Dejan ^a   VanRollins, Mike ^a   Li, Ke ^a   Montine, Kathleen S ^a   Montine, Thomas J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Brain; Isoprostane; Neuroprostane; Oxidative damage; Tocopherol

Indexed keywords

ANTIOXIDANTS; BRAIN; DISEASE CONTROL; GAS CHROMATOGRAPHY; IMMUNOLOGY; MASS SPECTROMETRY; THERMOOXIDATION;

ISOPROSTANE; NEUROPROSTANE; OXIDATIVE DAMAGE; TOCOPHEROL;

NEUROLOGY;

ALPHA TOCOPHEROL; GAMMA TOCOPHEROL; ISOPROSTANE DERIVATIVE; KAINIC ACID; LIPOPOLYSACCHARIDE; NEUROPROSTANE DERIVATIVE; NEUROPROTECTIVE AGENT; PROSTANOID; STABLE ISOTOPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; EXCITOTOXICITY; GAS CHROMATOGRAPHY; IMMUNE RESPONSE; IN VIVO STUDY; INHIBITION KINETICS; INNATE IMMUNITY; ION MONITORING; ISOTOPE DILUTION ASSAY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ALPHA-TOCOPHEROL; ANIMALS; BRAIN; DOCOSAHEXAENOIC ACIDS; F2-ISOPROSTANES; GAMMA-TOCOPHEROL; IMMUNITY, NATURAL; KAINIC ACID; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; NEUROTOXICITY SYNDROMES;

ANIMALIA; MURINAE;

EID: 27644574348     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2005.03.037     Document Type: Article

References (32)

1. Y. Gilgun-Sherki, Z. Rosenbaum, E. Melamed, and D. Offen Pharmacol. Rev. 54 2002 271
2. B. Halliwell Drugs Aging 18 2001 685
3. D.A. Butterfield, J. Drake, C. Pocernich, and A. Castegna Trends Mol. Med. 7 2001 548
4. T.J. Montine, and D.G. Graham D.I. Graham P. Lantos Greenfield's Neuropathology 2002 Arnold London 799
5. E. Polazzi, and A. Contestabile Rev. Neurosci. 13 2002 221
6. D.L. Vargas, C. Nascimbene, C. Krishnan, A.W. Zimmerman, and C.A. Pardo Ann. Neurol. 57 2005 67
7. M.N. Patel Free Radic. Res. 36 2002 1139
8. T. Grunewald, and M.F. Beal Ann. N. Y. Acad. Sci. 893 1999 203
9. T.J. Montine, D. Milatovic, R.C. Gupta, T. Valyi-Nagy, J.D. Morrow, and R.M. Breyer J. Neurochem. 83 2002 463
10. S. Zaja-Milatovic, D. Milatovic, A.M. Schantz, J. Zhang, K.S. Montine, A. Samii, A.Y. Deutch, and T.J. Montine Neurology 64 2005 545
11. J.L. Imler, and J.A. Hoffmann Trends Cell Biol. 11 2001 304
12. S. Akira J. Biol. Chem. 278 2003 38105
13. K. Fassbender, S. Walter, S. Kuhl, R. Landmann, K. Ishii, T. Bertsch, A.K. Stalder, F. Muehlhauser, Y. Liu, A.J. Ulmer, S. Rivest, A. Lentschat, E. Gulbins, M. Jucker, M. Staufenbiel, K. Brechtel, J. Walter, G. Multhaup, B. Penke, Y. Adachi, T. Hartmann, and K. Beyreuther FASEB J. 18 2004 203
14. O.D. Moffatt, A. Devitt, E.D. Bell, D.L. Simmons, and C.D. Gregory J. Immunol. 162 1999 6800
15. D.C. Anthony, T.J. Montine, and D.G. Graham C.D. Klaasen Casarett and Doull's Toxicology: The Basic Science of Poisons 2001 McGraw-Hill New York 535
16. J.E. Huettner Prog. Neurobiol. 70 2003 387
17. T.J. Montine, M.D. Neely, J.F. Quinn, M.F. Beal, W.R. Markesbery, L.J. Roberts II, and J.D. Morrow Free Radic. Biol. Med. 33 2002 620
18. J.D. Morrow, and L.J. Roberts Prog. Lipid Res. 36 1997 1
19. L.J. Roberts II, T.J. Montine, W.R. Markesbery, A.R. Tapper, P. Hardy, S. Chemtob, W.D. Dettbarn, and J.D. Morrow J. Biol. Chem. 273 1998 13605
20. K.S. Montine, J.F. Quinn, J. Zhang, J.P. Fessel, L.J. Roberts II, J.D. Morrow, and T.J. Montine Chem. Phys. Lipids 128 2004 117
21. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider, and L.J. Thal N. Engl. J. Med. 336 1997 1216
22. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal, R.S. Wilson, and P.A. Scherr JAMA 287 2002 3230
23. M.J. Engelhart, M.I. Geerlings, A. Ruitenberg, J.C. van Swieten, A. Hofman, J.C. Witteman, and M.M. Breteler JAMA 287 2002 3223
24. R. Brigelius-Flohe, and M.G. Traber FASEB J. 13 1999 1145
25. C. Montero-Menie, L. Sindji, A. Pouplard, F. Jehan, L. Denechaud, and F. Darcy Brain Res. 653 1994 101
26. D. Milatovic, S. Zaja-Milatovic, K.S. Montine, P.J. Horner, and T.J. Montine J. Neurochem. 87 2003 1518
27. M. Lerner-Natoli, P. Montpied, M.C. Rousset, J. Bockaert, and G. Rondouin Epilepsy Res. 41 2000 141
28. E.E. Reich, W.R. Markesbery, L.J. Roberts II, L.L. Swift, J.D. Morrow, and T. Montine Am. J. Pathol. 158 2001 293
29. I. Jialal, M. Traber, and S. Devaraj Curr. Opin. Lipidol. 12 2001 49
30. M. Clement, L. Dinh, and J.M. Bourre Biochim. Biophys. Acta 1256 1995 175
31. S. Christen, A.A. Woodall, M.K. Shigenaga, P.T. Southwell-Keely, M.W. Duncan, and B.N. Ames Proc. Natl. Acad. Sci. U.S.A. 94 1997 3217
32. S. Zaja-Milatovic, D. Milatovic, A.M. Schantz, J. Zhang, K.S. Montine, A. Samii, A.Y. Deutch, and T.J. Montine Neurology 64 2005 545